MCDADE MARK

CIK 000124212610 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001242126

Recent Transactions

50 trades

Disposition to Issuer
Tourmaline Bio, Inc.$TRML
Employee Stock Option (Right to Buy)
2025-10-28−10,000→ 0 total
Disposition from Tender
Tourmaline Bio, Inc.$TRML
Common Stock
2025-10-28−183,177→ 0 total
Disposition to Issuer
Tourmaline Bio, Inc.$TRML
Employee Stock Option (Right to Buy)
2025-10-28−16,800→ 0 total
Disposition from Tender
Tourmaline Bio, Inc.$TRML
Common Stock
2025-10-28−110,083→ 0 total
Disposition to Issuer
Tourmaline Bio, Inc.$TRML
Employee Stock Option (Right to Buy)
2025-10-28−20,000→ 0 total
Disposition from Tender
Tourmaline Bio, Inc.$TRML
Common Stock
2025-10-28−448,431→ 0 total
Disposition from Tender
Tourmaline Bio, Inc.$TRML
Common Stock
2025-10-28−518→ 0 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2025-06-04+16,800→ 16,800 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2024-06-05+10,000→ 10,000 total
Disposition to Issuer
Icosavax, Inc.
Stock Option (Right to Buy)
2024-02-19−17,000→ 0 total
Disposition from Tender
Icosavax, Inc.
Common Stock
2024-02-19−55,786→ 0 total
Disposition to Issuer
Icosavax, Inc.
Stock Option (Right to Buy)
2024-02-19−22,278→ 0 total
Disposition from Tender
Icosavax, Inc.
Common Stock
2024-02-19−3,510,228→ 0 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2024-01-29$32.50/sh+100,000→ 448,431 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-10-23+20,000→ 20,000 total
Disposition to Issuer
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-10-19−20,500→ 0 total
Award
Tourmaline Bio, Inc.$TRML
Common Stock
2023-10-19+348,431→ 348,431 total
Award
Tourmaline Bio, Inc.$TRML
Common Stock
2023-10-19+518→ 518 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-06-13+20,500→ 20,500 total
Award
Icosavax, Inc.
Stock Option (Right to Buy)
2023-06-06+17,000→ 17,000 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-01-27$1.50/sh+2,666,666→ 8,519,648 total
Award
Icosavax, Inc.
Common Stock
2022-06-10+5,543→ 55,786 total
Award
Icosavax, Inc.
Stock Option (Right to Buy)
2022-06-10+22,278→ 22,278 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2022-06-09+14,501→ 14,501 total
Purchase
Icosavax, Inc.
Common Stock
2022-04-01$7.10/sh+42,225→ 50,243 total
Conversion
Icosavax, Inc.
Series A-1 Preferred Stock
2021-08-02−12,480,498→ 0 total
Purchase
Icosavax, Inc.
Common Stock
2021-08-02$15.00/sh+13,333→ 3,523,561 total
Purchase
Icosavax, Inc.
Common Stock
2021-08-02$15.00/sh+8,018→ 3,518,246 total
Conversion
Icosavax, Inc.
Common Stock
2021-08-02+3,310,228→ 3,310,228 total
Conversion
Icosavax, Inc.
Series B-1 Preferred Stock
2021-08-02−1,275,817→ 0 total
Purchase
Icosavax, Inc.
Common Stock
2021-08-02$15.00/sh+200,000→ 3,510,228 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$14.60/sh−11,432→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$31.48/sh−104,842→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$17.39/sh−15,398→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$16.24/sh−17,500→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-13$34.50/sh−7,840→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$19.10/sh−19,755→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$1.71/sh−7,500→ 0 total
Disposition from Tender
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-10$34.50/sh−26,852→ 0 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-05-27+7,840→ 34,692 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-05-27+15,398→ 15,398 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−7,758→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−3,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−23,275→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−10,344→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Common Stock
2020-02-20$18.75/sh−6,000→ 0 total
Exercise/Conversion
Dermira, Inc.
Common Stock
2019-06-12−3,000→ 0 total

Companies

Recent Filings

Address

280 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov